Selank vs Semax — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Selank is a synthetic tuftsin analog approved in Russia for generalized anxiety disorder. It modulates GABA-A receptors and preserves endogenous enkephalins via enkephalinase inhibition, producing anxiolytic and nootropic effects without sedation or dependence. Administered intra...
Calculate Selank dose →Semax is a synthetic ACTH(4-10) heptapeptide analog approved in Russia for cognitive impairment and ischemic stroke. It upregulates BDNF and TrkB in the hippocampus, enhancing neuroplasticity and focus. Administered primarily intranasally with CNS effects lasting 24+ hours despit...
Calculate Semax dose →| Parameter | Selank | Semax |
|---|---|---|
| Category | Cognitive & Anxiolytic | Cognitive & Nootropic |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | ~2 min (plasma); CNS effects 24h+ | ~minutes (plasma); CNS effects 24h+ |
| Typical Dose | 250–750 µg intranasal | 300–900 µg intranasal |
| Frequency | Once or twice daily | Once or twice daily |
| Route | Intranasal (primary) / Subcutaneous | Intranasal (primary) / Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.